pamidronate has been researched along with Arthralgia in 5 studies
Arthralgia: Pain in the joint.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Transient migratory osteoporosis is characterized by the acute onset of migratory pain at weight-bearing joints." | 5.34 | Transient migratory osteoporosis: rapid response to pamidronate treatment. ( Carty, S; Herdman, G; Srinivasan, U; Williams, F, 2007) |
| "Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug." | 5.10 | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. ( Aaron, SL; Chiu, P; Davis, P; Fitzgerald, AA; Homik, J; Jhangri, GS; LeClercq, S; Maksymowych, WP; Russell, AS; Sholter, D; Skeith, KJ; Yan, A, 2002) |
| "Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
| "Transient migratory osteoporosis is characterized by the acute onset of migratory pain at weight-bearing joints." | 1.34 | Transient migratory osteoporosis: rapid response to pamidronate treatment. ( Carty, S; Herdman, G; Srinivasan, U; Williams, F, 2007) |
| "Pachydermoperiostosis is manifested by finger clubbing, hypertrophic skin changes, and periosteal bone formation." | 1.31 | Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. ( Chastanet, P; Cortet, B; Cotten, A; Delcambre, B; Deprez, X; Flipo, RM; Guyot-Drouot, MH; Solau-Gervais, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leblicq, C | 1 |
| Laverdière, C | 1 |
| Décarie, JC | 1 |
| Delisle, JF | 1 |
| Isler, MH | 1 |
| Moghrabi, A | 1 |
| Chabot, G | 1 |
| Alos, N | 1 |
| Carty, S | 1 |
| Herdman, G | 1 |
| Williams, F | 1 |
| Srinivasan, U | 1 |
| MacGowan, JR | 1 |
| Pringle, J | 1 |
| Morris, VH | 1 |
| Stamp, TC | 1 |
| Guyot-Drouot, MH | 1 |
| Solau-Gervais, E | 1 |
| Cortet, B | 1 |
| Deprez, X | 1 |
| Chastanet, P | 1 |
| Cotten, A | 1 |
| Delcambre, B | 1 |
| Flipo, RM | 1 |
| Maksymowych, WP | 1 |
| Jhangri, GS | 1 |
| Fitzgerald, AA | 1 |
| LeClercq, S | 1 |
| Chiu, P | 1 |
| Yan, A | 1 |
| Skeith, KJ | 1 |
| Aaron, SL | 1 |
| Homik, J | 1 |
| Davis, P | 1 |
| Sholter, D | 1 |
| Russell, AS | 1 |
2 trials available for pamidronate and Arthralgia
| Article | Year |
|---|---|
Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.
Topics: Adolescent; Arthralgia; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; F | 2013 |
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diphosphonates | 2002 |
3 other studies available for pamidronate and Arthralgia
| Article | Year |
|---|---|
Transient migratory osteoporosis: rapid response to pamidronate treatment.
Topics: Adult; Aged; Arthralgia; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infusions | 2007 |
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |
Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Humans; Injections, Intravenous; | 2000 |